Levomethadone (INN; L-Polamidon L-Polamivet Levadone Levothyl) or levamethadone is a synthetic opioid analgesic and antitussive which is marketed in Europe and is used for pain management and in opioid maintenance […]
List of articles in "Drug" category - Page 38
ACH-3102
ACH-3102 is an investigational new drug in development for the treatment of the viral infection known as hepatitis C. It is an NS5A inhibitor. The NS5A protein serves multiple functions […]
Nafoxadol
Nafoxadol (INN) is an analgesic drug which was never marketed.
Naloxegol
Naloxegol (INN; NKTR-118) or PEGylated naloxol is a peripherally-selective opioid antagonist under development by AstraZeneca licensed from Nektar for the treatment of opioid-induced constipation.
Drinabant
Drinabant (INN; AVE-1625) is a drug that acts as a selective CB1 receptor antagonist which was under investigation varyingly by Sanofi-Aventis as a treatment for obesity schizophrenia Alzheimer’s disease Parkinson’s […]
Rosonabant
Rosonabant (INN; E-6776) is a drug acting as a CB1 receptor antagonist/inverse agonist that was under investigation by Esteve as an appetite suppressant for the treatment of obesity. Development of […]
Levofenfluramine
Levofenfluramine (INN) or (-)-3-trifluoromethyl-N-ethylamphetamine also known as (-)-fenfluramine or (R)-fenfluramine is a drug of the amphetamine family that itself (i.e. in enantiopure form) was never marketed. It is the levorotatory […]
Fasinumab
Fasinumab is a human monoclonal antibody designed for the treatment of pain.This drug was developed by Regeneron Pharmaceuticals.
Demcizumab
Demcizumab is a humanized monoclonal antibody designed for the treatment of cancer.This drug was developed by OncoMed Pharmaceuticals.
Alirocumab
Alirocumab is a human monoclonal antibody designed for the treatment of hypercholesterolemia. This therapeutic is also known by the codes REGN727 and SAR236553.This drug was discovered by Regeneron Pharmaceuticals and […]